Search

Tandem Diabetes Care Inc

Slēgts

SektorsVeselības aprūpe

17.53 8.34

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

16.17

Max

17.98

Galvenie mērījumi

By Trading Economics

Ienākumi

-775K

-21M

Pārdošana

7.3M

255M

EPS

-0.31

Peļņas marža

-8.316

Darbinieki

2,500

EBITDA

4.5M

-9.2M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+62.56% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 5. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-209M

1.2B

Iepriekšējā atvēršanas cena

9.19

Iepriekšējā slēgšanas cena

17.53

Ziņu noskaņojums

By Acuity

50%

50%

129 / 339 Rangs Healthcare

Tandem Diabetes Care Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 16. sept. 19:05 UTC

Tandem Diabetes Care Inc is sharply higher on Wednesday, maintaining upward momentum since Tuesday's close despite an earlier pullback from a session high.

2026. g. 11. sept. 20:01 UTC

Tandem Diabetes Care Inc is trading lower today, breaking a trend of higher daily closes. No specific news has been identified to explain the decline.

2026. g. 10. sept. 20:03 UTC

Tandem Diabetes Care Inc's shares are lower today, remaining near session lows. Broader market volatility follows the European Central Bank's interest rate hike.

2026. g. 9. sept. 20:07 UTC

Tandem Diabetes Care shares are lower today amid broader market pressures, with significant selling activity contributing to a session decline. No specific news was identified.

2026. g. 8. sept. 19:26 UTC

Social Media

Tandem Diabetes Care is advancing amid discussions of Modular Medical's product launch targeting hesitant insulin pump users, with FDA clearance and a new pharmacy contract.

2026. g. 4. sept. 20:08 UTC

Tandem Diabetes Care Inc shares are lower, continuing a five-session decline amid broader selling pressure following a strong jobs report.

2026. g. 1. sept. 20:02 UTC

Tandem Diabetes Care is trading lower amid broader economic concerns, including rising oil prices and inflation worries impacting interest rate expectations.

2026. g. 31. aug. 20:03 UTC

News

Tandem Diabetes Care Inc shares are higher during Monday's session, rebounding sharply after an initial dip amid broader market volatility from recent economic remarks.

2026. g. 27. aug. 20:07 UTC

Tandem Diabetes Care Inc shares are higher today, reflecting a modest overall market gain. No specific news was identified to explain the movement.

2026. g. 25. aug. 20:07 UTC

Tandem Diabetes Care shares are lower today, continuing a trend of five consecutive daily declines. Earlier, the stock reached a session high before pulling back.

2026. g. 24. aug. 19:36 UTC

News

Tandem Diabetes Care shares are lower today, following a downward trend since Friday. Analysts maintain a "Hold" consensus, with targets ranging from $18 to $40.

2026. g. 21. aug. 19:46 UTC

Tandem Diabetes Care Inc. shares are roughly flat today, showing some volatility with a high of 2.13% and a low of -2.80%.

2026. g. 20. aug. 20:02 UTC

Tandem Diabetes Care Inc shares are lower amid broader market pressures following Walmart Inc's disappointing earnings report, raising concerns about consumer spending.

2026. g. 19. aug. 19:46 UTC

Tandem Diabetes Care Inc. shares are higher, reflecting routine performance amid a broader rebound in stock prices linked to declining bond yields.

2026. g. 18. aug. 20:01 UTC

Tandem Diabetes Care is trading higher today, reflecting strong intraday performance despite recent lower finishes. The stock remains above its 20-day moving average.

2026. g. 17. aug. 19:46 UTC

News

Tandem Diabetes Care shares are lower as investor caution follows its Q2 earnings report, despite meeting revenue and profit expectations.

2026. g. 14. aug. 20:06 UTC

Tandem Diabetes Care shares are lower today amid economic concerns following a disappointing U.S. retail sales report for July. The stock remains above its 20-day moving average.

2026. g. 13. aug. 19:16 UTC

Tandem Diabetes Care shares are trading lower today, despite broader market support and an early high. Initial jobless claims rose, indicating potential labor market softening.

2026. g. 12. aug. 19:41 UTC

News

Tandem Diabetes Care reported a narrower second-quarter loss of 31 cents per share, with revenues of $254.6 million, as shares rise since Tuesday.

2026. g. 11. aug. 19:46 UTC

News

Tandem Diabetes Care reported improved second-quarter results, including a narrower loss and increased revenue, supporting shares' advance during Tuesday's session.

2026. g. 10. aug. 19:36 UTC

News

Tandem Diabetes Care reported second-quarter revenue of $254.6 million and reaffirmed its full-year guidance of $1.08 billion, supporting a higher share price today.

2026. g. 7. aug. 20:02 UTC

News

Tandem Diabetes Care shares rose after Q2 sales of $254.6 million and adjusted EBITDA of $6.4 million exceeded forecasts, despite RBC lowering its price target to $26.

2026. g. 6. aug. 23:02 UTC

News

Tandem Diabetes Care reported Q2 sales of $254.6 million and reaffirmed revenue guidance, with shares trading higher in after-market hours.

2026. g. 5. aug. 19:56 UTC

News

Tandem Diabetes Care Inc's shares are declining amid negative sentiment in the insulin sector following Insulet Corp's lowered revenue growth forecast.

2026. g. 4. aug. 19:46 UTC

Tandem Diabetes Care Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. Earlier, the stock reached a session high before pulling back.

2026. g. 31. jūl. 19:51 UTC

Tandem Diabetes Care Inc is advancing today, benefiting from positive market sentiment driven by technology stocks, despite pulling back from earlier session highs.

2026. g. 30. jūl. 17:11 UTC

Tandem Diabetes Care shares are lower today as the Health Care Equipment sub-sector declines. The asset remains above its 20-day moving average.

2026. g. 29. jūl. 18:15 UTC

Tandem Diabetes Care Inc. shares are higher, driven by significant gains in Health Care Equipment stocks, despite a recent trend of daily price increases.

2026. g. 27. jūl. 19:21 UTC

Tandem Diabetes Care Inc. shares are lower, reflecting broader market trends amid declining oil prices and easing geopolitical tensions ahead of the Federal Reserve meeting.

2026. g. 24. jūl. 14:02 UTC

Tandem Diabetes Care Inc shares are lower today, with no specific news identified. Broader market concerns follow a significant sell-off on Thursday.

Salīdzinājums

Cenas izmaiņa

Tandem Diabetes Care Inc Prognoze

Cenas mērķis

By TipRanks

62.56% augšup

Prognoze 12 mēnešiem

Vidējais 26.464 USD  62.56%

Augstākais 50 USD

Zemākais 15.5 USD

Pamatojoties uz 15 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Tandem Diabetes Care Inc  — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

15 ratings

8

Pirkt

7

Turēt

0

Pārdot

Noskaņojums

By Acuity

129 / 339 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
help-icon Live chat